SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

bioAffinity Technologies, Inc. – IPO: ‘S-1/A’ on 8/18/22 – ‘EX-16.1’

On:  Thursday, 8/18/22, at 5:03pm ET   ·   Accession #:  1493152-22-23475   ·   File #:  333-264463

Previous ‘S-1’:  ‘S-1/A’ on 8/5/22   ·   Next:  ‘S-1’ on 9/20/23   ·   Latest:  ‘S-1’ on 4/4/24   ·   11 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/18/22  bioAffinity Technologies, Inc.    S-1/A                 10:7M                                     M2 Compliance LLC/FA

Initial Public Offering (IPO):  Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   3.01M 
                (General Form)                                                   
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML    568K 
 5: EX-4.15     Instrument Defining the Rights of Security Holders  HTML    182K 
 3: EX-4.6      Instrument Defining the Rights of Security Holders  HTML    181K 
 4: EX-4.7      Instrument Defining the Rights of Security Holders  HTML    188K 
 6: EX-5.1      Opinion of Counsel re: Legality                     HTML     27K 
 8: EX-23.2     Consent of Expert or Counsel                        HTML      7K 
 9: EX-23.3     Consent of Expert or Counsel                        HTML      7K 
10: EX-FILING FEES  Filing Fees                                     HTML    103K 
 7: EX-16.1     Letter re: a Change in Accountant                   HTML      7K 


‘EX-16.1’   —   Letter re: a Change in Accountant


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

EXHIBIT 16.1

 

August 18, 2022

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

Ladies and Gentlemen:

 

We have read bioAffinity Technologies, Inc.’s statements included in its Form S-1 dated August 18, 2022, and are in agreement with the statements contained in the Management’s Discussion and Analysis of Financial Conditions and Results of Operations section titled “Change in Auditors” in the first four paragraphs of that section therein. We have no basis to agree or disagree with other statements of the registrant contained therein.

 

/s/ Ernst & Young LLP

 

 C: 
 

 


Dates Referenced Herein

This ‘S-1/A’ Filing    Date    Other Filings
Filed on:8/18/22None on these Dates
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/05/24  bioAffinity Technologies, Inc.    POS AM                 2:173K                                   M2 Compliance LLC/FA
 4/02/24  bioAffinity Technologies, Inc.    POS AM                75:7.5M                                   M2 Compliance LLC/FA
 8/14/23  bioAffinity Technologies, Inc.    DRS9/20/23    1:2.7M                                   M2 Compliance LLC/FA
 4/19/23  bioAffinity Technologies, Inc.    S-8         4/19/23    4:161K                                   M2 Compliance LLC/FA
 3/31/23  bioAffinity Technologies, Inc.    10-K       12/31/22   75:5.4M                                   M2 Compliance LLC/FA
 8/23/22  bioAffinity Technologies, Inc.    8-A12B/A               1:27K                                    M2 Compliance LLC/FA


5 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/05/22  bioAffinity Technologies, Inc.    S-1/A                  9:6.7M                                   M2 Compliance LLC/FA
 7/28/22  bioAffinity Technologies, Inc.    S-1/A                 17:7.3M                                   M2 Compliance LLC/FA
 6/16/22  bioAffinity Technologies, Inc.    S-1/A                 13:8.5M                                   M2 Compliance LLC/FA
 5/25/22  bioAffinity Technologies, Inc.    S-1/A                 33:61M                                    M2 Compliance LLC/FA
 4/25/22  bioAffinity Technologies, Inc.    S-1                    6:5.2M                                   M2 Compliance LLC/FA
Top
Filing Submission 0001493152-22-023475   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 10:28:38.2am ET